Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Taiwan Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Electrosurgical Instruments, Guiding Devices, Inflation Systems), by Application (Neurosurgeryv, Cosmetic Surgery, Urology, Obstetrics and Gynecology, Ophthalmology, Cardiovascular, Orthopedic Surgery, Laparoscopy, Others) and by End User (Hospitals, Ambulatory Surgical Clinics, Research Institute): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04500

Pages: NA

Charts: NA

Tables: NA

 Key Market Segments

  • By Product
    • Handheld Instruments
    • Electrosurgical Instruments
    • Guiding Devices
    • Inflation Systems
  • By Application
    • Neurosurgeryv
    • Cosmetic Surgery
    • Urology
    • Obstetrics and Gynecology
    • Ophthalmology
    • Cardiovascular
    • Orthopedic Surgery
    • Laparoscopy
    • Others
  • By End User
    • Hospitals
    • Ambulatory Surgical Clinics
    • Research Institute

 
Key Market Players

  • Richard Wolf GmbH
  • Haag-Streit AG
  • JEDMED Instrument Co
  • Tegra Medical
  • Eli TW Surgical Co Ltd
  • Farco-Tech Co Ltd
  • Neaton Medical Co Ltd
  • Zimmer Biomet
  • Huifeng Medical Co Ltd
  • Nuance Medical Instruments Co Ltd

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Handheld Instruments

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Electrosurgical Instruments

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Guiding Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Inflation Systems

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Neurosurgeryv

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cosmetic Surgery

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Urology

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Obstetrics And Gynecology

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Ophthalmology

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Cardiovascular

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Orthopedic Surgery

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

    • 5.9. Laparoscopy

      • 5.9.1. Key Market Trends, Growth Factors and Opportunities

      • 5.9.2. Market Size and Forecast, By Region

      • 5.9.3. Market Share Analysis, By Country

    • 5.10. Others

      • 5.10.1. Key Market Trends, Growth Factors and Opportunities

      • 5.10.2. Market Size and Forecast, By Region

      • 5.10.3. Market Share Analysis, By Country

  • CHAPTER 6: TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Research Institute

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S.

        • 7.2.6.1 Market size and forecast, product

        • 7.2.6.2 Market size and forecast, application

        • 7.2.6.3 Market size and forecast, end user

      • 7.2.7. Canada

        • 7.2.7.1 Market size and forecast, product

        • 7.2.7.2 Market size and forecast, application

        • 7.2.7.3 Market size and forecast, end user

      • 7.2.8. Mexico

        • 7.2.8.1 Market size and forecast, product

        • 7.2.8.2 Market size and forecast, application

        • 7.2.8.3 Market size and forecast, end user

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France

        • 7.3.6.1 Market size and forecast, product

        • 7.3.6.2 Market size and forecast, application

        • 7.3.6.3 Market size and forecast, end user

      • 7.3.7. Germany

        • 7.3.7.1 Market size and forecast, product

        • 7.3.7.2 Market size and forecast, application

        • 7.3.7.3 Market size and forecast, end user

      • 7.3.8. Italy

        • 7.3.8.1 Market size and forecast, product

        • 7.3.8.2 Market size and forecast, application

        • 7.3.8.3 Market size and forecast, end user

      • 7.3.9. Spain

        • 7.3.9.1 Market size and forecast, product

        • 7.3.9.2 Market size and forecast, application

        • 7.3.9.3 Market size and forecast, end user

      • 7.3.10. UK

        • 7.3.10.1 Market size and forecast, product

        • 7.3.10.2 Market size and forecast, application

        • 7.3.10.3 Market size and forecast, end user

      • 7.3.11. Russia

        • 7.3.11.1 Market size and forecast, product

        • 7.3.11.2 Market size and forecast, application

        • 7.3.11.3 Market size and forecast, end user

      • 7.3.12. Rest Of Europe

        • 7.3.12.1 Market size and forecast, product

        • 7.3.12.2 Market size and forecast, application

        • 7.3.12.3 Market size and forecast, end user

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China

        • 7.4.6.1 Market size and forecast, product

        • 7.4.6.2 Market size and forecast, application

        • 7.4.6.3 Market size and forecast, end user

      • 7.4.7. Japan

        • 7.4.7.1 Market size and forecast, product

        • 7.4.7.2 Market size and forecast, application

        • 7.4.7.3 Market size and forecast, end user

      • 7.4.8. India

        • 7.4.8.1 Market size and forecast, product

        • 7.4.8.2 Market size and forecast, application

        • 7.4.8.3 Market size and forecast, end user

      • 7.4.9. South Korea

        • 7.4.9.1 Market size and forecast, product

        • 7.4.9.2 Market size and forecast, application

        • 7.4.9.3 Market size and forecast, end user

      • 7.4.10. Australia

        • 7.4.10.1 Market size and forecast, product

        • 7.4.10.2 Market size and forecast, application

        • 7.4.10.3 Market size and forecast, end user

      • 7.4.11. Thailand

        • 7.4.11.1 Market size and forecast, product

        • 7.4.11.2 Market size and forecast, application

        • 7.4.11.3 Market size and forecast, end user

      • 7.4.12. Malaysia

        • 7.4.12.1 Market size and forecast, product

        • 7.4.12.2 Market size and forecast, application

        • 7.4.12.3 Market size and forecast, end user

      • 7.4.13. Indonesia

        • 7.4.13.1 Market size and forecast, product

        • 7.4.13.2 Market size and forecast, application

        • 7.4.13.3 Market size and forecast, end user

      • 7.4.14. Rest of Asia Pacific

        • 7.4.14.1 Market size and forecast, product

        • 7.4.14.2 Market size and forecast, application

        • 7.4.14.3 Market size and forecast, end user

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil

        • 7.5.6.1 Market size and forecast, product

        • 7.5.6.2 Market size and forecast, application

        • 7.5.6.3 Market size and forecast, end user

      • 7.5.7. South Africa

        • 7.5.7.1 Market size and forecast, product

        • 7.5.7.2 Market size and forecast, application

        • 7.5.7.3 Market size and forecast, end user

      • 7.5.8. Saudi Arabia

        • 7.5.8.1 Market size and forecast, product

        • 7.5.8.2 Market size and forecast, application

        • 7.5.8.3 Market size and forecast, end user

      • 7.5.9. UAE

        • 7.5.9.1 Market size and forecast, product

        • 7.5.9.2 Market size and forecast, application

        • 7.5.9.3 Market size and forecast, end user

      • 7.5.10. Argentina

        • 7.5.10.1 Market size and forecast, product

        • 7.5.10.2 Market size and forecast, application

        • 7.5.10.3 Market size and forecast, end user

      • 7.5.11. Rest of LAMEA

        • 7.5.11.1 Market size and forecast, product

        • 7.5.11.2 Market size and forecast, application

        • 7.5.11.3 Market size and forecast, end user

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Farco-Tech Co Ltd

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Huifeng Medical Co Ltd

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Haag-Streit AG

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Eli TW Surgical Co Ltd

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Richard Wolf GmbH

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Tegra Medical

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. JEDMED Instrument Co

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Neaton Medical Co Ltd

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Zimmer Biomet

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Nuance Medical Instruments Co Ltd

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HANDHELD INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ELECTROSURGICAL INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GUIDING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR INFLATION SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 7. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NEUROSURGERYV, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OBSTETRICS AND GYNECOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OPHTHALMOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOVASCULAR, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR LAPAROSCOPY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGICAL CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR RESEARCH INSTITUTE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 25. U.S. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. U.S. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. U.S. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. CANADA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. CANADA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. CANADA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. GERMANY TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. ITALY TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. ITALY TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. ITALY TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. SPAIN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. UK TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. UK TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. UK TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. RUSSIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. RUSSIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. RUSSIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. REST OF EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. REST OF EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. REST OF EUROPE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. ASIA-PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. ASIA-PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. ASIA-PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 63. CHINA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. CHINA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. CHINA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. JAPAN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. JAPAN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. JAPAN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. INDIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. INDIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. INDIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. SOUTH KOREA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. SOUTH KOREA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. SOUTH KOREA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. AUSTRALIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. AUSTRALIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. AUSTRALIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. THAILAND TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. THAILAND TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. THAILAND TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. MALAYSIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. MALAYSIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. MALAYSIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. INDONESIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. INDONESIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. INDONESIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. REST OF ASIA PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 88. REST OF ASIA PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 94. BRAZIL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 95. BRAZIL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. BRAZIL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 97. SOUTH AFRICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 98. SOUTH AFRICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH AFRICA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. SAUDI ARABIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. SAUDI ARABIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. SAUDI ARABIA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. UAE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 104. UAE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 105. UAE TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. ARGENTINA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 107. ARGENTINA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. ARGENTINA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. REST OF LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. REST OF LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. FARCO-TECH CO LTD: KEY EXECUTIVES
  • TABLE 113. FARCO-TECH CO LTD: COMPANY SNAPSHOT
  • TABLE 114. FARCO-TECH CO LTD: OPERATING SEGMENTS
  • TABLE 115. FARCO-TECH CO LTD: PRODUCT PORTFOLIO
  • TABLE 116. FARCO-TECH CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. HUIFENG MEDICAL CO LTD: KEY EXECUTIVES
  • TABLE 118. HUIFENG MEDICAL CO LTD: COMPANY SNAPSHOT
  • TABLE 119. HUIFENG MEDICAL CO LTD: OPERATING SEGMENTS
  • TABLE 120. HUIFENG MEDICAL CO LTD: PRODUCT PORTFOLIO
  • TABLE 121. HUIFENG MEDICAL CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. HAAG-STREIT AG: KEY EXECUTIVES
  • TABLE 123. HAAG-STREIT AG: COMPANY SNAPSHOT
  • TABLE 124. HAAG-STREIT AG: OPERATING SEGMENTS
  • TABLE 125. HAAG-STREIT AG: PRODUCT PORTFOLIO
  • TABLE 126. HAAG-STREIT AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. ELI TW SURGICAL CO LTD: KEY EXECUTIVES
  • TABLE 128. ELI TW SURGICAL CO LTD: COMPANY SNAPSHOT
  • TABLE 129. ELI TW SURGICAL CO LTD: OPERATING SEGMENTS
  • TABLE 130. ELI TW SURGICAL CO LTD: PRODUCT PORTFOLIO
  • TABLE 131. ELI TW SURGICAL CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. RICHARD WOLF GMBH: KEY EXECUTIVES
  • TABLE 133. RICHARD WOLF GMBH: COMPANY SNAPSHOT
  • TABLE 134. RICHARD WOLF GMBH: OPERATING SEGMENTS
  • TABLE 135. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
  • TABLE 136. RICHARD WOLF GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. TEGRA MEDICAL: KEY EXECUTIVES
  • TABLE 138. TEGRA MEDICAL: COMPANY SNAPSHOT
  • TABLE 139. TEGRA MEDICAL: OPERATING SEGMENTS
  • TABLE 140. TEGRA MEDICAL: PRODUCT PORTFOLIO
  • TABLE 141. TEGRA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. JEDMED INSTRUMENT CO: KEY EXECUTIVES
  • TABLE 143. JEDMED INSTRUMENT CO: COMPANY SNAPSHOT
  • TABLE 144. JEDMED INSTRUMENT CO: OPERATING SEGMENTS
  • TABLE 145. JEDMED INSTRUMENT CO: PRODUCT PORTFOLIO
  • TABLE 146. JEDMED INSTRUMENT CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. NEATON MEDICAL CO LTD: KEY EXECUTIVES
  • TABLE 148. NEATON MEDICAL CO LTD: COMPANY SNAPSHOT
  • TABLE 149. NEATON MEDICAL CO LTD: OPERATING SEGMENTS
  • TABLE 150. NEATON MEDICAL CO LTD: PRODUCT PORTFOLIO
  • TABLE 151. NEATON MEDICAL CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. ZIMMER BIOMET: KEY EXECUTIVES
  • TABLE 153. ZIMMER BIOMET: COMPANY SNAPSHOT
  • TABLE 154. ZIMMER BIOMET: OPERATING SEGMENTS
  • TABLE 155. ZIMMER BIOMET: PRODUCT PORTFOLIO
  • TABLE 156. ZIMMER BIOMET: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. NUANCE MEDICAL INSTRUMENTS CO LTD: KEY EXECUTIVES
  • TABLE 158. NUANCE MEDICAL INSTRUMENTS CO LTD: COMPANY SNAPSHOT
  • TABLE 159. NUANCE MEDICAL INSTRUMENTS CO LTD: OPERATING SEGMENTS
  • TABLE 160. NUANCE MEDICAL INSTRUMENTS CO LTD: PRODUCT PORTFOLIO
  • TABLE 161. NUANCE MEDICAL INSTRUMENTS CO LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
  • FIGURE 3. SEGMENTATION TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALTAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
  • FIGURE 11. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 12. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HANDHELD INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ELECTROSURGICAL INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR GUIDING DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR INFLATION SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 17. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR NEUROSURGERYV, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR COSMETIC SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR UROLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OBSTETRICS AND GYNECOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR CARDIOVASCULAR, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR LAPAROSCOPY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET SEGMENTATION, BY END USER
  • FIGURE 27. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR AMBULATORY SURGICAL CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET FOR RESEARCH INSTITUTE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: TAIWAN MINIMALLY INVASIVE SURGICAL INSTRUMENTS MARKET
  • FIGURE 36. TOP PLAYER POSITIONING,2022
  • FIGURE 37. FARCO-TECH CO LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. FARCO-TECH CO LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. FARCO-TECH CO LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. HUIFENG MEDICAL CO LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. HUIFENG MEDICAL CO LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. HUIFENG MEDICAL CO LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. HAAG-STREIT AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. HAAG-STREIT AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. HAAG-STREIT AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. ELI TW SURGICAL CO LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. ELI TW SURGICAL CO LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. ELI TW SURGICAL CO LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. RICHARD WOLF GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. RICHARD WOLF GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. RICHARD WOLF GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. TEGRA MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. TEGRA MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. TEGRA MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. JEDMED INSTRUMENT CO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. JEDMED INSTRUMENT CO: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. JEDMED INSTRUMENT CO: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. NEATON MEDICAL CO LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. NEATON MEDICAL CO LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. NEATON MEDICAL CO LTD: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. ZIMMER BIOMET: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 64. NUANCE MEDICAL INSTRUMENTS CO LTD: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. NUANCE MEDICAL INSTRUMENTS CO LTD: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 66. NUANCE MEDICAL INSTRUMENTS CO LTD: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Taiwan Minimally Invasive Surgical Instruments Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved